Clearance of the neurotropic JHM strain of mouse hepatitis virus from the central nervous system was examined by the transfer of spleen cells from immunized donors. A T cell with the surface phenotype of Thyl.2+ CD4+ CD8-asialo-GM,' Mac-1-was found to be necessary for viral clearance. The surface phenotype and adherence to nylon wool suggest that these cells are activated helper-inducer T cells. Adoptive transfer to congenic histocompatibility strains demonstrated the necessity for compatibility at the D locus of the major histocompatibility complex. The expression of the CD4 surface marker and the requirement for major histocompatibility complex class I were further studied by the transfer of cells to recipients treated with anti-CD4 or anti-CD8 monoclonal antibodies. Treatment of recipients with either the anti-CD8 or the anti-CD4 antibodies inhibited virus clearance from the central nervous system. This suggests that the CD4+ cell acts as a helper and that virus is cleared from the central nervous system by CD8+ cells that recognize viral antigen in the context of the H-2Db gene product.
Infection with the JHM neurotropic strain of mouse hepatitis virus (JHMV) results in an acute encephalomyelitis with demyelination in both mice and rats (6, 15, 25, 26, 33, 36, 37 ). Demyelination appears to result from a lytic infection of oligodendroglial cells (15, 37) . Survivors show evidence of chronic demyelination with persistent viral antigen (6, 14) ; however, infectious virus has rarely been recovered from animals with chronic disease (14) . It has recently been suggested that a myelin-specific autoimmune response can be induced during JHMV infection (34) ; however, the relative roles of autoimmunity and persistent viral infection in the pathogenesis of the chronic phase of JHMV-induced demyelination are not clear. Although JHMV induces both T-and B-cell responses, the mechanism of virus clearance from the central nervous system (CNS) has not been examined. Antibody is apparently ineffective in eliminating virus from the CNS, since antiviral antibody is often detected in the cerebrospinal fluid during chronic CNS infections, including infections with JHMV (5, 7) . Indeed, the adoptive transfer of anti-JHMV monoclonal antibodies protects susceptible mice from lethal JHMV infection (2, 6a, 17, 21, 35); however, these antibodies have little effect on the replication of JHMV in the CNS (2, 6a, 35) . Although the mechanism of protection in the absence of suppression of viral replication is not clear, it has been noted that following administration of the antiviral antibodies, infection occurred predominantly in oligodendroglial cells, with little or no infection of neurons (2, 6a). These observations are consistent with our recent report of a monoclonal antibody-selected variant of JHMV that replicates in the CNS almost as well as parental JHMV but is not fatal (8) . This variant also preferentially infects glial cells but not neurons, suggesting that survival of JHMV infection is correlated with the absence of neuronal infection (8) .
Cell-mediated immunity has also been shown to be important in protection from JHMV infection. The adoptive trans-fer of JHMV-specific CD4+ polyclonal splenic T cells and delayed-type hypersensitivity (DTH) inducer T-cell clones prevents death due to JHMV infection (30, 31) . No decrease in CNS viral titer accompanied DTH inducer T-cell-mediated protection (30, 31) , and predominant infection of glial cells in the white matter was found in protected animals (S. S. Erlich, G. K. Matsushima, and S. A. Stohlman, J. Neurol. Sci., in press).
The titer of JHMV in the CNS peaks early in infection and then declines (30) . It is not known whether cytotoxic T cells participate in either protection or viral clearance during JHMV infection in vivo, although the clearance of infectious virus is generally accomplished by CD8+ major histocompatibility complex (MHC) class I-restricted cytotoxic T cells. Three cell types have been described which exhibit cytotoxicity for mouse hepatitis virus-infected cells in vitro, including an NK-like cell (3), a cytolytic B cell (11) . and CD8+ cytotoxic T cells (40). However, their role in the antiviral immune response in the CNS is unclear. Although protection from a lethal JHMV infection can be at least partially attributed to both DTH inducer T cells and antiviral antibody, neither of these effector mechanisms suppressed viral growth in the CNS.
The goal of this study was to examine the ability of immune cells to reduce virus titer in the CNS during JHMV infection. We have identified a nylon-wool-adherent (NWA) CD4+ T cell which may function as a helper cell for the induction of MHC class I (Db)-restricted CD8+ cells, which are apparently the primary effectors in reducing virus titer in the CNS of JHMV-infected mice.
cell line, were grown in minimal essential medium (GIBCO Laboratories, Grand Island, N.Y.) containing 7%c newborn calf serum (Biocell Laboratories, Carson, Calif.), 100 U of penicillin per ml and 100 Vig of streptomycin per ml (GIBCO) at 37°C in a humidified atmosphere containing 7.5% CO,. L-2 fibroblast cells were maintained in Spinner flasks (Wheaton Industries, Millville, N.J.) containing Joklik medium (GIBCO) supplemented with 8% fetal calf serum (FCS) at 370C.
Virus and viral antigen. Viruses were propagated on DBT cells in minimal essential medium containing 10% tryptose phosphate broth and 2% fetal bovine serum (Irvine Scientific, Irvine, Calif.). The viral titer was determined by a plaque assay with DBT cells as previously described (8, 29, 39) . Mice were inoculated intracerebrally with approximately 5 x 103 PFU of the DS strain of JHMV in a volume of 0.03 ml. Immunizations were performed by intraperitoneal injection of 1.0 ml containing approximately 1 x 106 PFU of JHMV. Viral titers in the brains of infected mice were determined by limiting-dilution analysis with L-2 cells in 24-well plates as previously described (31) . JHMV antigen used for DTH footpad tests consisted of a lysate of infected DBT cells sonicated in phosphate-buffered saline (pH 7.2), as previously described (30, 31, 39 DTH. Footpad swelling was used as a measure of DTH as previously described (30, 31, 39) . (Table 1) . Spleen cells from immunized mice were applied to nylon wool columns to enrich for T cells as previously described (31) . Both the NWNA and NWA fractions were adoptively transferred to lethally infected mice. The NWNA population failed to significantly reduce the viral titer in recipient mice, even though it contained approximately 80%Y of the total T cells (Table 1) . Surprisingly, the active cells were found in the NWA fraction (Table  1) . The titer decrease in mice receiving pooled NWNA and NWA fractions was not significantly different from the reduction of viral titer in recipients of NWA cells alone (Table 1) .
To determine the surface phenotype of the cells responsible for the reduction of the JHMV titer, antibody-pluscomplement lysis was used to deplete NWA cells of cells expressing specific surface markers before the cells were transferred to JHMV-infected recipients. Depletion of the Thy-1+ population from the NWA fraction completely inhibited the reduction of JHMV titer in the brains of infected mice ( 23% of the total Thy-i' cells (data not shown). Since we had previously shown that CD4+ DTH inducer T cells were unable to reduce the JHMV titer (30, 31) , cells expressing CD8 were also depleted. However, depletion of CD8-bearing T cells had no effect on the ability of the NWA cells to clear JHMW. Depletion of cells expressing asialo-GM, also resulted in the inhibition of viral clearance, suggesting the possibility that natural-killer (NK) cells participate in JHMV clearance. NK cells are generally NWNA and express asialo-GM1, NK1.1, and low or undetectable levels of Thy-I (10). Since some T cells also express asialo-GM1 (28), it was important to distinguish between these two cell types. Antibodies to the NK cell marker, NK1.1, and to CD4 were used in depletion experiments ( (30, 31) , although both express the Thy-1 and CD4 cell surface markers.
Role of CD8+ cells. The data in Table 2 suggest that CD4 + T cells play a major role in the clearance of JHMV from the CNS. CD4+ cells usually function as helper cells, although CD4+ class II-restricted cytotoxic effector cells have been described (18) . To (Table 2) . To directly address the ability of the NWA CD4+ cells to provide help for antiviral CD8+ cells, we treated recipient mice with either anti-L3T4 or anti-Lyt-2 antibody. The JHMV titer in the brain was determined 5 days following the transfer of the NWA cells. As expected, treatment with anti-L3T4 antibody completely inhibited the ability of the NWA cells to alter the JHMV titer in the brain (Table 4) . Similarly, treatment with anti-Lyt-2 was clearly able to inhibit the ability of the NWA cells to reduce the viral titer in the brain. This suggests that the CD4+ cell in the NWA population functions as a helper to induce a CD8+ primary effector cell.
Histocompatibility at MHC class I is required for JHMV titer reduction. To determine the requirement for histocompatibility, we first demonstrated that the adoptive transfer of spleen cells from immunized C57BL/6 (H-2*) or C3Heb/Fe (H-2k) donors to mice of the same haplotype reduced the viral titer over 5,000-fold. Transfer of spleen cells from immunized donors to H-2 mismatched strains, for example, C57BL/6 into C3Heb/Fe, resulted in no decrease in the JHMV titer (data not shown). The necessity for histocompatibility at MHC class I and/or class II loci was examined by adoptive transfers of cells between various congenic donor strains. Table 5 shows the ability of cells from congenic donors to reduce the viral titer in the brains of C57BL/6 recipients. Total histocompatibility between donor and recipient resulted in a ca. 10,000-fold reduction in the viral titer. C57BL/6 recipients of cells from immunized Restriction of the D locus was further investigated by the adoptive transfer of cells from immunized C57BL/6 mice into congenic recipients. The requirement for D-region compatibility was confirmed by using B10.A(2R) (KkIkDb) recipient mice (Table 6 ). Cells from C57BL/6 donors (H-2b) which matched at the D locus of the B10.A(2R) strain resulted in an approximately 300-fold decrease in the titer. Cells donated to B1O.A(5R) or B10.MBR strains which matched C57BL/6 at the K and I loci had little effect on the JHMV titer (10-to 20-fold), similar to the effect observed in totally histoincompatible B1O.BR mice (H-2k; approximately 10-fold). These experiments demonstrate that histocompatibility at the MHC class I D locus is necessary between the donated NWA T cells and the recipient mouse for reduction of the JHMV titer.
DISCUSSION
The ability of JHMV to infect oligodendroglial cells in the CNS of mice and rats and induce an acute encephalomyelitis accompanied by demyelination has been studied extensively as a model of human multiple sclerosis (6) . It is generally accepted that the immune response plays an active role in the JHMV-induced establishment of chronic infection and ongoing demyelination. The role of antibody in the pathogenesis of JHMV infection has been studied by the adoptive transfer of JHMV-specific monoclonal antibodies and also by infection of newborn mice born of immunized mothers (23, 24) . Anti-JHMV antibody prevents death from JHMV infection; however, protection does not result from direct virus neutralization, since none of the monoclonal antibodies tested to date are potent inhibitors of virus replication in the CNS (2, 6a, 35 ). In addition, we have recently shown that, at least in the case of nonneutralizing antibodies specific for the viral El matrix protein, clearance of JHMV does not occur Expressed as log PFU per gram of braiin tissue + one standard deviaition of the mean. Three mice were tested per grouLp.
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d Titer from mice of the same strain and age as recipients which did not receive transferred spleen cells.
via antibody-mediated complement-dependent lysis of infected cells (6a) . The inability of antibody to reduce the viral titer in the CNS of protected mice, as well as results of studies of both nude mice and rats and animals immunosuppressed by lethal irradiation, suggests that cell-mediated immunity plays a critical role in the pathogenesis of JHMV infection (2, 6a, 13, 27) . The adoptive transfer of either NWNA polyclonal JHMV-induced DTH effector T cells or JHMV-specific DTH inducer T-cell clones also protects mice from lethal JHMV infection. However, since neither of these cell populations was able to reduce the viral titer in the CNS (30, 31) 
